Virtu KCG Holdings’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Virtu KCG Holdings’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$150K	Buy	+3,091	New	+$542K	﹤0.01%	2292
2016 Q4	–	Sell	-190	Closed	-$19K	–	3934
2016 Q3	$19K	Sell	190 -536	-74%	-$49.1K	﹤0.01%	2924
2016 Q2	$64K	Buy	726 +465	+178%	+$41.7K	﹤0.01%	2629
2016 Q1	$14K	Sell	261 -67	-20%	-$5.18K	﹤0.01%	2629
2015 Q4	$41K	Buy	+328	New	+$216K	﹤0.01%	3196

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Virtu KCG Holdings's EVFM Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2017: 3,091 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #2292 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in EVFM as recently as Q3 2016.

Virtu KCG Holdings first reported a position in EVFM in Q4 2015 and has held it in 5 quarters since. 15 funds tracked by Wall St. Rank hold EVFM as of Q2 2017.

Virtu KCG Holdings held 3,091 shares of Evofem Biosciences, Inc. Common Stock worth $150K as of Q2 2017.
Evofem Biosciences, Inc. Common Stock was a new Virtu KCG Holdings position in Q2 2017.
Evofem Biosciences, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2292 holding.
Virtu KCG Holdings first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
15 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.